Cargando…

Delta neutrophil index in obese and non-obese polycystic ovary syndrome patients

OBJECTIVE: We aimed to evaluate the usefulness of delta neutrophil index (DNI), a new inflammatory marker, in polycystic ovary syndrome (PCOS). METHODS: This retrospective case-control study was conducted at a tertiary health center. The DNI and other blood parameters obtained from the complete bloo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Günday, Özlem Kayacık, Yılmazer, Mehmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Obstetrics and Gynecology 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514584/ https://www.ncbi.nlm.nih.gov/pubmed/37500074 http://dx.doi.org/10.5468/ogs.22310

Ejemplares similares

Analysis of Endocrine and Metabolic Indexes in Non-Obese Patients with Polycystic Ovary Syndrome and Its Compare with Obese Patients
por: Shi, Wenjing, et al.
Publicado: (2021)

Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome
por: Riemann, Annika, et al.
Publicado: (2022)

Insulin level, lipid profile, and HOMA index in lean and obese patients with polycystic ovary syndrome
por: Hussein, Shamim Riadh Mohammed, et al.
Publicado: (2023)

Ovulation induction by metformin among obese versus non-obese women with polycystic ovary syndrome
por: Al-Ruthia, Yazed Sulaiman, et al.
Publicado: (2017)

Pharmacological Management of Obesity in Patients with Polycystic Ovary Syndrome
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)

Why are women with polycystic ovary syndrome obese?
por: Barber, T M
Publicado: (2022)

Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome
por: Agacayak, Elif, et al.
Publicado: (2015)

Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome
por: Tziomalos, Konstantinos, et al.
Publicado: (2018)

Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
por: López-Alarcón, Mardia, et al.
Publicado: (2023)

Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
por: Moran, Carlos, et al.
Publicado: (2012)

Serum visfatin levels in non-obese women with polycystic ovary syndrome and matched controls
por: Kim, Jin Ju, et al.
Publicado: (2018)

An overview of polycystic ovary syndrome in aging women
por: Çelik, Özlem, et al.
Publicado: (2021)

Effect of hyperlipidemia on the outcome of in vitro fertilization in non-obese patients with polycystic ovary syndrome
por: Yang, Fang, et al.
Publicado: (2023)

Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity
por: Couto Alves, A, et al.
Publicado: (2017)

Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. Non- Obese Women
por: Saadia, Zaheera
Publicado: (2020)

Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients
por: Butler, Alexandra E., et al.
Publicado: (2023)

Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
por: Gateva, Antoaneta, et al.
Publicado: (2012)

Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome
por: Zhou, Jiaojiao, et al.
Publicado: (2021)

Renal resistive index in patients with polycystic ovary syndrome
por: Tüfekçioğlu, Gülsen, et al.
Publicado: (2019)

Polycystic ovary syndrome: Is obesity a sine qua non? A clinical, hormonal, and metabolic assessment in relation to body mass index
por: Saxena, Pikee, et al.
Publicado: (2012)

Polycystic Ovary Syndrome and Obesity: A Cross-Sectional Survey of Patients and Obstetricians/Gynecologists
por: Gill, Lisa, et al.
Publicado: (2023)

Adrenocortical steroid response to ACTH in different phenotypes of non-obese polycystic ovary syndrome
por: Cinar, Nese, et al.
Publicado: (2012)

Anti-Inflammatory Dietary Combo in Overweight and Obese Women with Polycystic Ovary Syndrome
por: Salama, Amany Alsayed, et al.
Publicado: (2015)

Altered cardiorespiratory response to exercise in overweight and obese women with polycystic ovary syndrome
por: Rissanen, Antti‐Pekka E., et al.
Publicado: (2016)

Quality of life in overweight (obese) and normal-weight women with polycystic ovary syndrome
por: Panico, Annalisa, et al.
Publicado: (2017)

Assessment of neutrophil to lymphocyte ratio, C-reactive protein, mean platelet volume in obese, and nonobese patients with polycystic ovary syndrome
por: Liu, Wenhua, et al.
Publicado: (2022)

Probiotics and Polycystic Ovary Syndrome: A Perspective for Management in Adolescents with Obesity
por: Calcaterra, Valeria, et al.
Publicado: (2023)

The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome
por: Chen, Jie, et al.
Publicado: (2015)

Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
por: Rojas, Joselyn, et al.
Publicado: (2014)

Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome
por: Deng, Yuying, et al.
Publicado: (2017)

Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
por: Barber, Thomas M, et al.
Publicado: (2019)

Efficacy of Bariatric Surgery in the Treatment of Women With Obesity and Polycystic Ovary Syndrome
por: Hu, Lili, et al.
Publicado: (2022)

New Therapeutic Approaches in Obesity and Metabolic Syndrome Associated with Polycystic Ovary Syndrome
por: Saleem, Fatima, et al.
Publicado: (2017)

Leptin and body mass index in polycystic ovary syndrome
por: Jalilian, Nasrin, et al.
Publicado: (2016)

Neck Circumference as a Predictor of Obesity and Metabolic Syndrome in Bangladeshi Women with Polycystic Ovary Syndrome
por: Kamrul-Hasan, A. B. M., et al.
Publicado: (2021)

Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome
por: Kałużna, Małgorzata, et al.
Publicado: (2022)

High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome
por: Butler, Alexandra E., et al.
Publicado: (2023)

Body Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypes
por: Bagir, Gulay Simsek, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ogcosd8pc29mu977g0l3caeat4